{"transactions":[{"id":778912,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:26:26.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on the first anniversary of May 12, 2026."}],"balance_after":10683,"source":{"system":"sec-edgar","filing":"0001193125-26-224140","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526224140/ownership.xml","form_type":"4"}},{"id":1145296,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:05:10.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-25-073516","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025073516/ownership.xml","form_type":"4"}},{"id":1188798,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-28T20:00:03.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.7,"value":7000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects a reverse stock split of the Issuer's common stock at a ratio of 12:1 effective April 2018. The Reporting Person disclaims beneficial ownership of 11 shares of common stock owned by his spouse except to the extent of his pecuniary interest in the shares."}],"balance_after":10257,"source":{"system":"sec-edgar","filing":"0000950170-25-046742","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017025046742/ownership.xml","form_type":"4"}},{"id":1465741,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-01T20:00:12.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over 12 months following June 27, 2024, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024 with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.05,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-079562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000095017024079562/ownership.xml","form_type":"4"}},{"id":1902693,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-05T23:36:00.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months.  The options were issued at approximately 9:50 a.m. (ET) on May 4, 2023, with an exercise price of $0.662, representing the most recently reported closing stock price on May 3, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.662,"expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-23-012871","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774923012871/rdgdoc.xml","form_type":"4"}},{"id":2270262,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T22:21:20.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:30 a.m. (ET) on May 13, 2022, with an exercise price of $0.93, representing the most recently reported closing stock price on May 12, 2022."}],"balance_after":50000,"derivative":{"exercise_price":0.93,"expiration_date":"2032-05-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-22-012711","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774922012711/rdgdoc.xml","form_type":"4"}},{"id":2708034,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T20:18:08.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-21-012673","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774921012673/rdgdoc.xml","form_type":"4"}},{"id":3142662,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-05-19T18:06:57.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-20-011265","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774920011265/rdgdoc.xml","form_type":"4"}},{"id":3516846,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-05-22T00:07:06.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant."}],"balance_after":45000,"derivative":{"exercise_price":2.52,"expiration_date":"2029-05-17","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001437749-19-010645","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000143774919010645/rdgdoc.xml","form_type":"4"}},{"id":3880464,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:04:05.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on a quarterly basis over the next 12 months."}],"balance_after":45000,"derivative":{"exercise_price":2.38,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001615774-18-006000","document":"s111133_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577418006000/s111133_form4.xml","form_type":"4"}},{"id":4302949,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-26T17:50:21.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":57685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the policies of Pryor Cashman, the law firm of which Mr. Remmel is a partner, the options Mr. Remmel receives for his services as a director are assigned to the firm."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest on a quarterly basis over the next 12 months."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the policies of Pryor Cashman, the law firm of which Mr. Remmel is a partner, the options Mr. Remmel receives for his services as a director are assigned to the firm."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Pursuant to the policies of Pryor Cashman, the law firm of which Mr. Remmel is a partner, the options Mr. Remmel receives for his services as a director are assigned to the firm."}],"balance_after":75369,"derivative":{"exercise_price":0.47,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":57685},"source":{"system":"sec-edgar","filing":"0001615774-17-002745","document":"s106364_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577417002745/s106364_form4.xml","form_type":"4"}},{"id":4350661,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":47320,"kind":"person","name":"Remmel H. Lawrence","position":1,"cik":"0001551817","reported_name":"Remmel H. Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-18T21:10:27.000Z","date":"2017-04-17","kind":"purchase","acquired":true,"shares":2500,"price":0.632,"value":1580.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person disclaims beneficial ownership of the 133 shares of common stock held by the Reporting Person's spouse and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person disclaims beneficial ownership of the 133 shares of common stock held by the Reporting Person's spouse and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":3126,"source":{"system":"sec-edgar","filing":"0001615774-17-001757","document":"s105907_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488039/000161577417001757/s105907_form4.xml","form_type":"4"}}]}